Effectiveness and Safety of CELSTAT for Hemostasis in Intraoperative Tissue Bleeding
NCT02640235 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260
Last updated 2020-08-03
Summary
The study is to evaluate the effectiveness and safety of CELSTAT vs active control.
Conditions
- Bleeding Active
Interventions
- DEVICE
-
CELSTAT
- DEVICE
-
Surgicel Original
Sponsors & Collaborators
-
Baxter Healthcare Corporation
lead INDUSTRY
Principal Investigators
-
Qing Li, MD · Baxter Healthcare Corporation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-24
- Primary Completion
- 2017-07-21
- Completion
- 2017-10-18
Countries
- United States
- Czechia
- Germany
- Poland
Study Locations
More Related Trials
-
EVARREST™ Fibrin Sealant Patch Post-Market Study
NCT01902459 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection
NCT02769754 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System
NCT02359994 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery
NCT02284256 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Evaluating XSTAT Use in the Prehospital Setting
NCT04663087 ·Status: TERMINATED ·Phase: NA
-
Blood Characteristics and Abdominal Emergency Surgery
NCT06028854 ·Status: SUSPENDED
-
Postoperative Bleeding Prevention in Massive Bone Tumour Resection
NCT02153593 ·Status: TERMINATED ·Phase: PHASE3
-
The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study
NCT03255174 ·Status: COMPLETED ·Phase: PHASE3
-
Adjusted Fibrinogen Replacement Strategy
NCT03444324 ·Status: COMPLETED ·Phase: PHASE3
-
Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.
NCT01008436 ·Status: TERMINATED ·Phase: NA
-
Factor Replacement in Surgery
NCT04114643 ·Status: UNKNOWN ·Phase: PHASE2
-
ACCEL Absorbable Hemostat
NCT04728087 ·Status: RECRUITING ·Phase: NA
-
QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding
NCT04415606 ·Status: COMPLETED ·Phase: NA
-
ClotFoam as an Adjunct to Hemostasis in Abdominal Surgery - Liver Bleeding is Encountered
NCT02264730 ·Status: UNKNOWN ·Phase: PHASE1
-
The Fibrin Patch Soft Tissue Study
NCT00658723 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach
NCT01622946 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness Study of the Drug Tranexamic Acid to Reduce Post-surgery Blood Loss in Spinal Surgery
NCT02063035 ·Status: COMPLETED ·Phase: PHASE4
-
"Salvage Use" of Recombinant Factor VIIa After Inadequate Haemostasis in Complex Cardiac Surgery
NCT00214656 ·Status: UNKNOWN ·Phase: PHASE3
-
Observational Cohort Study of TachoSil (TC-018-IN)
NCT00285623 ·Status: COMPLETED
-
TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery
NCT01192022 ·Status: COMPLETED ·Phase: PHASE3
-
Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.
NCT00708513 ·Status: COMPLETED
-
Seraseal for Endoscopic Hemostasis
NCT02349490 ·Status: COMPLETED ·Phase: PHASE4
-
Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery
NCT07105904 ·Status: COMPLETED
-
Study of Recombinant Human Thrombin for Bleeding During Surgery
NCT00245336 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery
NCT04660721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2